Do you like our site?
The use of estrogen/progesterone containing Birth Control Pills have long been known to slightly increase one’s risk for Venous Thromboembolic events (i.e., deep vein blood clots.) Recent reports have put into question additional increased risk by use of BCPs containing the progesterone, dropserinone (Yasmin, Yaz, Beyaz, and their generics.) Available studies on this issue are inconsistent, some studies showing a fractional increased risk, others showing no increased risk. In comparing risks of VTE, the increased risk from any Birth Control Pill (3-9/10,000) is still significantly less than the increased risk of VTE in pregnancy (5-20/10,000), and the immediate post-delivery time period (40-65/10,000)… According to the FDA’s advisory committee, the benefits of all contraceptive methods still outweigh the risks.
(See WXYZ's interview with Dr. Suzanne Hall on their recent story on Yaz
We spend a good amount of time explaining tests and test results to patients during routine office visits. One particular test often leads patients’ to anxiety and misunderstanding: The Quad Screen.
The Quad Screen is a test from the mothers blood, drawn between 15 and 20 weeks of pregnancy. The goal of the test is to evaluate the risk (or chance) that the current pregnancy is affected by Down’s Syndrome, or, more rarely, other chromosome abnormalities.
A woman may utilize emergency contraception after a sexual encounter without protection or contraception. Common indications include condom breakage and individual missing doses of oral contraception.
The US market offers two major products. One contains estrogen and progesterone taken 12 hours apart. The other contains progesterone only taken in a single dose or 12 hours apart.